STELLABODY
Live / Registered — Registered (as of 04 Jun 2024)
What this means for you
Registered since 04 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79354136
- Registration number
- 7404002
- Mark type
- Stylized text
- Filed
- 08 Sept 2022
- Published for opposition
- 19 Mar 2024
- Registered
- 04 Jun 2024
- Attorney of record
- Charles G. Zug
Goods and services
- Class 001 — Chemicals: Immunological antibodies, other than for medical use; reagents for scientific purposes; diagnostic reagents for scientific use; chemical testing reagents for scientific use; laboratory reagents for scientific use; biochemical preparations for laboratory purposes; immunoassay reagents, other than for medical use; enzymes for scientific purposes; chemical diagnostic reagents for scientific use; recombinant protein being biochemical preparations for scientific use
- Class 005 — Pharmaceuticals: Colostral antibodies for medical purposes; monoclonal antibodies for medical use; monoclonal antibodies for medical diagnostic use; tagged antibodies for medical use; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; monoclonal antibody reagents for medical use; clinical medical reagents for use in the development of monoclonal antibodies; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; chemical reagents for medical or veterinary purposes; immunoassay reagents for medical use; protein arrays for medical use in binding antibodies; protein arrays for medical use in detecting antibodies; biological preparations for pharmaceutical purposes for the treatment of autoimmune diseases and conditions, cancer, infectious, proliferative, metabolic, neurodegenerative, cardiovascular, neurologic, inflammatory, thrombotic, vascular, immune, and inflammatory diseases and conditions; immunological products, namely, pharmaceutical preparations for the treatment of autoimmune diseases and conditions, cancer, infectious, proliferative, metabolic, neurodegenerative, cardiovascular, neurologic, inflammatory, thrombotic, vascular, immune, and inflammatory diseases and conditions; pharmaceutical immunoglobulin preparations for treatment of immunological disorders; vaccines; vaccine adjuvants; pharmaceutical products for the treatment of autoimmune diseases and conditions, cancer, infectious, proliferative, metabolic, neurodegenerative, cardiovascular, neurologic, inflammatory, thrombotic, vascular, immune, and inflammatory diseases and conditions
Owner
Prosecution history
- 21 Dec 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 16 Nov 2024 — GENERIC MADRID TRANSACTION SENT TO IB
- 16 Nov 2024 — GENERIC MADRID TRANSACTION CREATED
- 04 Sept 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 04 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 22 Apr 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 03 Apr 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 Apr 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 19 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Mar 2024 — PUBLISHED FOR OPPOSITION
- 28 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED